FS-1502, an anti-HER2 ADC, in Patients with HER2-Expressing Advanced Solid Tumors: A Phase 1a Dose-Escalation StudyQiao Li,Xian Wang,Ying Cheng,Yunjiang Liu,Jianhua Chang,Zhuo Wang,Chunjiao Wu,Mingxia Wang,Ai-Min Hui,Zhuli Wu,Yongli Jin,Xin Huang,Liping Zhong,Lei Diao,Han Zhao,Binghe XuCANCER RESEARCH(2023)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要